07.08.11
Pharmalucence has selected Integrated Project Services to provide architectural design, engineering and construction of its pharmaceutical production facility in Billerica, MA.
Pharmalucence will build a new advanced aseptic manufacturing facility, creating 25 to 30 new positions during the next two years. Pharmalucence has initiated the first phase of construction for partial occupancy of the facility in late 2011. All phases of construction will be completed by mid-2012 with implementation of full drug manufacturing by mid-2013.
Ed Connolly, Pharmalucence’s chief operating officer, said, “Pharmalucence is making a major investment in the Boston area life sciences industry. We will secure and grow jobs while establishing state-of-the-art manufacturing methods for our own products and those of our contract manufacturing clients. IPS has designed and built award-winning pharmaceutical manufacturing projects featuring advanced aseptic technologies like those we will employ. Partnering with IPS enhances our potential for success.”
Dave Goswami, PE, president and chief operating officer IPS, said, “IPS is excited to provide the architectural, engineering and construction management services Pharmalucence needs to establish their new drug production asset in MA. Upon completion, Pharmalucence will gain best-in-class advanced aseptic fill/finish capacity to support its radiopharmaceutical manufacture and to advance its presence in the contract manufacturing market.”
Pharmalucence will build a new advanced aseptic manufacturing facility, creating 25 to 30 new positions during the next two years. Pharmalucence has initiated the first phase of construction for partial occupancy of the facility in late 2011. All phases of construction will be completed by mid-2012 with implementation of full drug manufacturing by mid-2013.
Ed Connolly, Pharmalucence’s chief operating officer, said, “Pharmalucence is making a major investment in the Boston area life sciences industry. We will secure and grow jobs while establishing state-of-the-art manufacturing methods for our own products and those of our contract manufacturing clients. IPS has designed and built award-winning pharmaceutical manufacturing projects featuring advanced aseptic technologies like those we will employ. Partnering with IPS enhances our potential for success.”
Dave Goswami, PE, president and chief operating officer IPS, said, “IPS is excited to provide the architectural, engineering and construction management services Pharmalucence needs to establish their new drug production asset in MA. Upon completion, Pharmalucence will gain best-in-class advanced aseptic fill/finish capacity to support its radiopharmaceutical manufacture and to advance its presence in the contract manufacturing market.”
